Clinical Study of Cizutamig in Systemic Lupus Erythematosus

Clinical trial NCT07215663 · RECRUITING

Trial details

NCT number: NCT07215663
Sponsor: Candid Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)

Start date: 2025-09-04
Primary completion: 2027-12-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.